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he RHD gene is responsible for the expression of the D antigen
hile RHCE encodes proteins carrying antigens C or c, and E
r e. RHD is present or absent depending on the RH haplotype,
nd RHCE displays four common alleles (ce, Ce, cE, CE) respon-
ible for the expression of the two antithetical (allelic) series
f antigens. RHD gene deletion is the leading cause of the D-
henotype worldwide.1 Functional (antigen) variations in the
h blood group system is determined by insertion/deletion,
ingle nucleotide polymorphisms (SNPs), and gene conversion
vents in the RHD and RHCE genes. A weak D type is a variant
f the RhD protein that comprises an amino acid substitution
ocated in the transmembraneous or intracellular segments
nd expresses a reduced amount of the D antigen [generally
ess than 5000 D antigens per red blood cell (RBC)].2,3
The RHD*weak D type 38 is produced by the single nucleotide
hange (833G>A) in the exon 6, causing a Gly278Asp substitu-
ion in the transmembraneous RhD protein. This RHD allele
hows reduced expression of the D antigen on the RBC sur-
ace and may be erroneously typed as D negative by standard
erologic methods.4–6 The frequencies of weak D type 38 vary
n different populations. The weak D type 38 was found in
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eserved.1.5% of Caucasians with the Ccee phenotype,4 while a rela-
tively higher frequency of 2.6% was recently detected among
Brazilians with the Ccee phenotype.6 Although the RHD*weak
D type 38 is considered a very rare allele, it is relatively com-
mon  in the Portuguese population.7 In this study we  analyzed
three generations of a family with RHD*weak D type 38 using
serologic and molecular methods.
Case  report
Family  study  and  blood  samples
A sample from a 45-year-old female blood donor was tested D
negative by routine serologic tests (Ccee phenotype) but posi-
tive by the adsorption-elution technique. In order to elucidate
these results we examined blood samples from 12 members
of her family were examined.
Immunohematologic serological tests were performed
using commercial monoclonal antibodies (MoAbs) MS-
26 + TH-28 and ESD1 by classical serology techniques,, SP, Brazil.
hemagglutination in gel cards (DiaMed, Latino América S.A.)
and by the tube methods with anti-D MoAbs IgM (HM10, P3X61,
P3X21211F1, P3X21223B10; Diagast, Loos, France) and anti-D
 e Terapia Celular. Published by Elsevier Editora Ltda. All rights
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ily with RHD*weak D type 38.
Table 1 – Pattern of reactivity seen with different clones
of anti-D antibodies and D antigen densities tested
against red blood cells from individuals with RHD*weak
D type 38.
Anti-D MoAb D epitope Isotype Reactivity
P3X249 2.1 G (±)
P3X290 3.1 G (−)
ESD1 4.1 G (−)
P3X35 5.4 G W
P3X241 5.4 G (±)
HM16 6.4 G W
P3X61 6.4 M (−)
HM10 6.6 M (−)
P3X21211F1 8.2 M (−)
P3X21223B10 9.1 M (−)
MS26 9.1 G (−)
D Antigen densitiesa 60–80 sites/cell
MoAb: monoclonal antibody; (−): negative result; W: weak result;
(±): very weak result.
aFigure 1 – Pedigree of fam
MoAbs IgG using the indirect antiglobulin test (IAT) (HM16,
P3X35, P3X241, P3X249, P3X290; Diagast, Loos, France). Rh
phenotypes were performed by hemagglutination in gel cards,
according to the manufacturer’s instructions (DiaMed, Latino
América S.A.) using polyclonal antibodies against D, C, c, E and
e.
The D antigen density of samples was determined by ﬂow
cytometry (FACSCalibur, Becton Dickinson, Heidelberg, Ger-
many)  according to a previously described protocol8 with
seven anti-D IgG MoAbs, HM16, P3X35, P3X241,P3X249, P3X290
(Diagast, Loos, France) and MS26 and ESD1 (DiaMed Latino
América S.A.).
Blood samples from family members were investigated by
polymerase chain reaction (PCR) with speciﬁc primers for two
genomic regions of the RHD gene, intron 4 and exon 10 and all
ten RHD exons were sequenced full length.9,10
We  found seven members of this family tested D negative
by routine serologic tests (Ccee phenotype) and positive by
the adsorption–elution technique. Their RBCs reacted nega-
tively to four IgM anti-D, but showed weakly positive results
with four IgG anti-D reagents (P3X249, P3X35, P3X241, HM16)
(Table 1). The ﬂow cytometric analysis of samples from these
seven subjects showed D antigen densities ranging from 60
to 80 sites per cell. Molecular analysis identiﬁed the presence
of RHD*weak D type 38 in three generations of this Brazilian
family (Figure 1).Discussion
This study revealed maternal inheritance (ﬁrst generation) of
the RHD*weak D type 38 with the Ccee phenotype by her ﬁveD antigen densities determined by ﬂow cytometry with anti-D IgG
monoclonal antibodies.
children and the second generation showed paternal inheri-
tance by a son. This family evaluation showed that RHD*weak
D type 38 was inherited as an ancestral allele.
In conclusion, this study found a relatively high prevalence
of RHD*weak D type 38 in Brazilians, remembering that Brazil
was colonized by the Portuguese.6,7 This is the ﬁrst report
showing the antigen densities of this weak D type with dif-
ferent MoAbs. The low D density found (60–80 sites/cell) could
explain why weak D type 38 subjects are routinely mistyped as
oter. 
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 negative by standard serologic methods including IAT. Thus,
his could represent a potential risk in blood transfusion since
nits of blood collected from these individuals could be trans-
used to D-negative recipients causing RhD alloimmunization.
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